Equities Analysts Set Expectations for Cooper Companies Inc’s Q1 2019 Earnings (COO)

Cooper Companies Inc (NYSE:COO) – Investment analysts at William Blair issued their Q1 2019 earnings estimates for shares of Cooper Companies in a report released on Saturday. William Blair analyst B. Weinstein expects that the medical device company will earn $2.91 per share for the quarter. William Blair also issued estimates for Cooper Companies’ Q2 2019 earnings at $3.14 EPS, Q3 2019 earnings at $3.38 EPS and Q4 2019 earnings at $3.47 EPS.

How to Become a New Pot Stock Millionaire

Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, March 8th. The medical device company reported $2.79 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.51 by $0.28. Cooper Companies had a net margin of 7.83% and a return on equity of 16.90%. The business had revenue of $590.00 million during the quarter, compared to analysts’ expectations of $583.07 million. During the same quarter in the prior year, the company posted $1.93 earnings per share. The firm’s revenue was up 18.2% on a year-over-year basis.

Other research analysts have also recently issued research reports about the stock. Cleveland Research cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Friday, February 9th. BMO Capital Markets restated an “outperform” rating and set a $280.00 target price (up previously from $277.00) on shares of Cooper Companies in a report on Friday, March 9th. TheStreet cut shares of Cooper Companies from a “b” rating to a “c” rating in a report on Thursday, March 8th. Oppenheimer set a $250.00 target price on shares of Cooper Companies and gave the stock a “hold” rating in a report on Friday, December 8th. Finally, Jefferies Group restated a “buy” rating and set a $285.00 target price on shares of Cooper Companies in a report on Friday, March 9th. Eight research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Cooper Companies presently has a consensus rating of “Hold” and an average price target of $267.50.

Shares of Cooper Companies (NYSE COO) traded down $0.89 on Tuesday, reaching $231.96. 83,931 shares of the company traded hands, compared to its average volume of 490,759. Cooper Companies has a fifty-two week low of $194.29 and a fifty-two week high of $260.26. The firm has a market capitalization of $11,553.85, a PE ratio of 66.72, a price-to-earnings-growth ratio of 1.85 and a beta of 0.61. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.83 and a quick ratio of 1.61.

A number of hedge funds and other institutional investors have recently bought and sold shares of COO. Crossmark Global Holdings Inc. bought a new stake in Cooper Companies during the third quarter worth $339,000. Canada Pension Plan Investment Board bought a new stake in Cooper Companies during the third quarter worth $163,000. Prudential Financial Inc. raised its position in Cooper Companies by 1.8% during the third quarter. Prudential Financial Inc. now owns 69,808 shares of the medical device company’s stock worth $16,552,000 after acquiring an additional 1,240 shares in the last quarter. New York State Common Retirement Fund raised its position in Cooper Companies by 0.5% during the third quarter. New York State Common Retirement Fund now owns 226,107 shares of the medical device company’s stock worth $53,612,000 after acquiring an additional 1,200 shares in the last quarter. Finally, Toronto Dominion Bank raised its position in shares of Cooper Companies by 12.0% in the third quarter. Toronto Dominion Bank now owns 18,536 shares of the medical device company’s stock valued at $4,395,000 after purchasing an additional 1,984 shares during the period. 98.53% of the stock is currently owned by hedge funds and other institutional investors.

In other Cooper Companies news, Director Stanley Md Zinberg sold 5,000 shares of the company’s stock in a transaction on Thursday, January 4th. The shares were sold at an average price of $224.66, for a total transaction of $1,123,300.00. Following the sale, the director now directly owns 6,090 shares of the company’s stock, valued at $1,368,179.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Allan E. Rubenstein sold 500 shares of the company’s stock in a transaction on Wednesday, December 27th. The stock was sold at an average price of $222.00, for a total transaction of $111,000.00. Following the sale, the director now directly owns 6,590 shares in the company, valued at $1,462,980. The disclosure for this sale can be found here. Insiders have sold 62,081 shares of company stock worth $14,879,687 over the last ninety days. Insiders own 1.60% of the company’s stock.

WARNING: “Equities Analysts Set Expectations for Cooper Companies Inc’s Q1 2019 Earnings (COO)” was originally published by Stock Observer and is the sole property of of Stock Observer. If you are reading this report on another publication, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.thestockobserver.com/2018/03/20/equities-analysts-set-expectations-for-cooper-companies-incs-q1-2019-earnings-coo.html.

Cooper Companies Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply